Lastly, phosphorylated ribosomal S6 kinase 1 (pS6K1), a downstream regulator of the mTOR pathway, was recently identified as a biomarker for adipogenesis, and its overexpression was associated with drug resistance and worse prognosis in breast cancer patients [20, 26]. This evidence concerns the gene MTOR and breast carcinoma.